These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9024746)

  • 1. Estrogen replacement therapy and exercise performance in postmenopausal women with coronary artery disease.
    Sbarouni E; Kyriakides ZS; Nikolaou N; Kremastinos DT
    Am J Cardiol; 1997 Jan; 79(1):87-9. PubMed ID: 9024746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of effects of short-term estrogen replacement therapy on resting and exertional QT and QTc dispersion in postmenopausal women with coronary artery disease.
    Sbarouni E; Zarvalis E; Kyriakides ZS; Kremastinos DT
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2392-5. PubMed ID: 9825354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of oestrogen replacement therapy on treadmill performance in postmenopausal women with coronary artery disease.
    Holdright DR; Sullivan AK; Wright CA; Sparrow JL; Cunningham D; Fox KM
    Eur Heart J; 1995 Nov; 16(11):1566-70. PubMed ID: 8881849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In normal postmenopausal women physiologic estrogen replacement therapy fails to improve exercise tolerance: a randomized, double-blind, placebo-controlled, crossover trial.
    Snabes MC; Herd JA; Schuyler N; Dunn K; Spence DW; Young RL
    Am J Obstet Gynecol; 1996 Jul; 175(1):110-4. PubMed ID: 8694035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does sublingual 17 beta-oestradiol have any effects on exercise capacity and myocardial ischaemia in post-menopausal women with stable coronary artery disease?
    al-Khalili F; Landgren BM; Eksborg S; Franco-Cereceda A; Schenck-Gustafsson K
    Eur Heart J; 1998 Jul; 19(7):1019-26. PubMed ID: 9717036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease.
    Redberg RF; Nishino M; McElhinney DB; Dae MW; Botvinick EH
    Am Heart J; 2000 Apr; 139(4):739-44. PubMed ID: 10740161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term estrogen therapy abolishes acute estrogen-induced coronary flow augmentation in postmenopausal women.
    Blumenthal RS; Brinker JA; Resar JR; Gloth ST; Zacur HA; Coombs V; Gerstenblith G; Reis SE
    Am Heart J; 1997 Mar; 133(3):323-8. PubMed ID: 9060801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy and exercise performance in postmenopausal women with coronary artery disease.
    Collins P; Rosano G
    Am J Cardiol; 1998 Jan; 81(2):259-60. PubMed ID: 9591921
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of estrogen on metabolic coronary vasodilator responses to atrial pacing in postmenopausal women.
    Anderson TJ
    Am J Cardiol; 1998 Jul; 82(2):236-9. PubMed ID: 9678297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age on the exercise response in normal postmenopausal women during estrogen replacement therapy.
    Seminario NA; Sciacca RR; DiTullio MR; Homma S; Giardina EG
    J Womens Health Gend Based Med; 1999 Dec; 8(10):1273-9. PubMed ID: 10643835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen replacement and exercise capacity in postmenopausal women: a randomized placebo-controlled study.
    Aldrighi JM; Calvoso-Júnior R; Alecrin IN; Trombetta IC; Negrão CE
    Gynecol Endocrinol; 2005 Dec; 21(6):324-9. PubMed ID: 16390780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic effects of hormone replacement therapy on the cardiovascular system in healthy postmenopausal women.
    Kirwan LD; MacLusky NJ; Shapiro HM; Abramson BL; Thomas SG; Goodman JM
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1618-29. PubMed ID: 15070921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise as an alternative to oral estrogen for amelioration of endothelial dysfunction in postmenopausal women.
    Harvey PJ; Picton PE; Su WS; Morris BL; Notarius CF; Floras JS
    Am Heart J; 2005 Feb; 149(2):291-7. PubMed ID: 15846267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
    Grodstein F; Manson JE; Colditz GA; Willett WC; Speizer FE; Stampfer MJ
    Ann Intern Med; 2000 Dec; 133(12):933-41. PubMed ID: 11119394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D
    N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X.
    Rosano GM; Peters NS; Lefroy D; Lindsay DC; Sarrel PM; Collins P; Poole-Wilson PA
    J Am Coll Cardiol; 1996 Nov; 28(6):1500-5. PubMed ID: 8917264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.